Pharmacology · Antituberculosis drugs
Aminosalicylic acid !
One of the oldest TB drugs (PAS), a PABA look-alike that disrupts the bacillus's folate pathway. Stomach upset limits its use.
Updated 2026-11-01
Also called: Para-aminosalicylic acid, PAS, 4-aminosalicylic acid
Mechanism of action
PAS is a structural analogue of para-aminobenzoic acid (PABA). It was long thought to compete at dihydropteroate synthase, but it behaves as a prodrug whose products block the folate pathway further down, starving the bacillus of the folate it needs to make DNA. It is bacteriostatic and acts only on M. tuberculosis.
- PAS enters the folate pathway in place of PABA
- Its products block later folate steps
- Without folate the bacillus stops multiplying
Pharmacokinetics
- Absorption
- High oral bioavailability; food increases it and reduces stomach irritation
- Metabolism
- Liver N-acetylation to a potentially hepatotoxic metabolite
- Elimination
- Mostly urine; reduced in renal failure
Indications
- Multidrug- or rifampicin-resistant tuberculosis, only when bedaquiline, linezolid, clofazimine or delamanid cannot be used Tuberculosis →
Adverse effects
Common
- Nausea, vomiting, diarrhoea, abdominal pain
- Hypersensitivity: rash, fever, eosinophilia
Contraindications
- G6PD deficiency
- Hypersensitivity to aminosalicylic acid
Key interactions
- Food
- Increase absorption and reduce stomach irritation; it is given after meals
What is monitored
- Gastrointestinal tolerance and adherence
- Liver tests
- Kidney function
- Signs of hypersensitivity
Administration and safety
- By mouth after meals, divided through the day
- Protected from light and moisture: it turns brown or purple when exposed
Nursing care
- Ask about nausea and diarrhoea, the main cause of stopping
- Check the G6PD status
- Teach to report rash or fever early
- Check storage: report discoloured granules to the pharmacy
Test yourself
Think of the answer, then tap the question to see it.
What molecule does PAS resemble?
Para-aminobenzoic acid (PABA), the folate pathway substrate.
Which adverse effect most limits PAS?
Gastrointestinal intolerance: nausea, vomiting and diarrhoea.
In whom is PAS avoided because of haemolysis?
People with G6PD deficiency.
Related drugs
Related conditions
← Back to the class: Antituberculosis drugs
Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.
Sources: WHO consolidated guidelines on tuberculosis: module 4: treatment and care (World Health Organization (WHO), 2025); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 65 (McGraw Hill, 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.